Kinetics and mechanism of the reaction of hydroxopentaaquarhodium(III) ion with l-Arginine in aqueous solution
- 80 Downloads
- 2 Citations
Abstract
The kinetics of the aqua ligand substitution from hydroxopentaaquarhodium(III) ion, [Rh(H2O)5(OH)]2+, by l-Arginine has been studied spectrophotometrically as a function of Arginine concentration, and temperature, at pH 4.3. The reaction proceeds via a rapid outer sphere association complex formation step followed by two consecutive steps. The first of these involves ligand-assisted anation, while the second involves chelation as the second aqua ligand is displaced. The association equilibrium constant for the outer sphere complex formation has been evaluated together with the rate constants for the two subsequent steps. The activation parameters for both steps have been evaluated using Eyring’s equation. Thermodynamic parameters calculated from the temperature dependence of the outer sphere association equilibrium constants are also consistent with an associative mode of activation. The product of the reaction has been characterized by conductivity measurement and IR spectroscopic analysis.
Keywords
Rhodium Platinum Group Metal Aqua Ligand Outer Sphere Complex Water Exchange RateReferences
- 1.Rosenberg B, Vancamp L, Trosko JE, Mansour VH (1969) Nature (London) 222:385CrossRefGoogle Scholar
- 2.Umapathy P (1989) Coord Chem Rev 95:129CrossRefGoogle Scholar
- 3.Clarke MJ (1980) In: Martell AE (ed) Inorganic chemistry in biology and medicine, ACS Symposium on Ser 140. American Chemical Society, Washington DC p. 157 and references cited thereinGoogle Scholar
- 4.Pruchink FP, Bien M, Lachowicz T (1996) Met Bas Drugs 3:185CrossRefGoogle Scholar
- 5.Clarke MJ (1980) Met Ions Biol Syst 11:231Google Scholar
- 6.Yasbin RE, Matthews CR, Clarke MJ (1980) Chem Biol Interact 31:355CrossRefGoogle Scholar
- 7.Cleare MJ, Hydes PC (1980) In: Siegel H (ed) Metal ions in biological systems, vol 2. Marcel Dekker, New York, pp 1–62Google Scholar
- 8.Monti-Bragadi C, Ramani L, Samer L, Mestroni G, Zassinovich G (1975) Antimicrob Agents Chemother 825Google Scholar
- 9.Mestroni G, Alessio GZ, Bontempi A (1987) Inorg Chim Acta 63:138Google Scholar
- 10.Katsaros N, Anagnostopoulou A (2002) Crit Rev Oncol Heamatol 42:297CrossRefGoogle Scholar
- 11.Metal in Medicine (2007) J Biol Inorg Chem 12(Suppl 1):S7Google Scholar
- 12.Kostova I (2006) Recent patents on anticancer drug discovery 1:1CrossRefGoogle Scholar
- 13.Kostova I (2006) Curr Med Chem 13:1085 and references thereinCrossRefGoogle Scholar
- 14.Pruchnik FP, Jakimowicz P, Cuinik Z, Zakrzewskaczerwinska J, Opolski A, Weitrzyk J, Wojdat E (2002) Inorg Chim Acta 334:59CrossRefGoogle Scholar
- 15.Gil ED, Serrano SHP, Ferreira EI, Kubota LT (2002) J Pharm Biomed Anal 29:579CrossRefGoogle Scholar
- 16.Tapiero H (2002) l-Arginine. Biomed Pharmacother 56:439CrossRefGoogle Scholar
- 17.Stechmiller JK (2005) Arginine supplementation and wound healing. Nutr Clin Practice 20:52CrossRefGoogle Scholar
- 18.Witte MB, Barbul A (2003) Arginine physiology and its implication for wound healing. Wound Repair Regenerat 11:419CrossRefGoogle Scholar
- 19.Ayres GH, Forrester JS (1957) J Inorg Nucl Chem 3:365CrossRefGoogle Scholar
- 20.Wolsey WC, Reynolds CA, Kleinberg J (1963) Inorg Chem 2:463CrossRefGoogle Scholar
- 21.Pneumatikakis G, Hadjiliadis N (1979) J Inorg Nucl Chem 41:429CrossRefGoogle Scholar
- 22.Steel D, Verhoeven PFM (2001) Vib Spectrosc 25:29CrossRefGoogle Scholar
- 23.Martell AE, Smith RM (1974) Critical stability constants, vol I: Amino acids. Plenum Press, New York, p 43Google Scholar
- 24.Banyai I, Glaser J, Read MC, Sand Stroem M (1995) Inorg Chem 34:2423CrossRefGoogle Scholar
- 25.Weyh JA, Hamm RE (1969) Inorg Chem 8:2298CrossRefGoogle Scholar
- 26.Jeffrey GA (1997) An introduction to hydrogen bonding. Oxford University Press, OxfordGoogle Scholar
- 27.Desiraju GR, Steiner T (1999) The weak hydrogen bonding in structural chemistry and biology. Oxford University Press, OxfordGoogle Scholar